Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Health
VS

Benchling vs Solugen: Valuation, Funding, Trajectory

Health Both private US-headquartered No Canborsa market

Benchling vs Solugen: two of the better-known names in health, compared side by side.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
BenchlingPRIVATE · US
SolugenPRIVATE · US
VS
Last valuation$6.1B$2B
Basis Post-money Post-money
As ofNov 2021Mar 2026
Founded20132016
Employees≈605≈115
On CanborsaNo marketNo market
At a glance
$6.1B
BenchlingPost-money, Series F · Nov 2021
$2B
SolugenPost-money, Series D expansion · Mar 2026
3.05×
GapBoth post-money, 52 months apart
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

Benchling vs Solugen — side by side

Field
BenchlingPRIVATE · FOUNDED 2013
SolugenPRIVATE · FOUNDED 2016
VS
Last valuation
$6.1B Post-money
$2B Post-money
Valuation date
1 Nov 2021
18 Mar 2026
Valuation basis
Post-money
Post-money
Latest round
Series F
Series D expansion
Round size
$100M
$50M
Round lead
Franklin Templeton, Altimeter Capital
Idealist Capital, Canada Growth Fund
Named investors
Altimeter Capital Franklin Templeton Tiger Global Sequoia Capital
Founded
2013
2016
Employees (est.)
≈605
≈115
Sector & HQ
Biotech/Research Software · US
Biotech / Green Chemistry · US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $6.1B for Benchling (post-money, Nov 2021) and $2B for Solugen (post-money, Mar 2026).

Benchling
$6.1BPost-money · Nov 2021
Solugen
$2BPost-money · Mar 2026
BENCHLING · $6.1B · NOV 2021SOLUGEN · $2B · MAR 2026
Benchling vs Solugen · what each company discloses

What each company discloses, and what it leaves out

BenchlingPRIVATEHealth · US · 2013
+Last disclosed mark $6.1B — post-money, Nov 2021.
+Founded 2013 .
+≈605 employees.
+Latest round: Series F, $100M raised, led by Franklin Templeton.
SolugenPRIVATEHealth · US · 2016
+Last disclosed mark $2B — post-money, Mar 2026.
+Founded 2016 .
+≈115 employees.
+Latest round: Series D expansion, $50M raised, led by Idealist Capital.
Verdict

Verdict

The $6.1B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$100M, led by Franklin Templeton in Nov 2021.
A dated print: it moves only when a newer round is announced.
The $2B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$50M, led by Idealist Capital in Mar 2026.
A dated print: it moves only when a newer round is announced.

Both marks are post-money, so 3.05× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

Are Benchling and Solugen in the same sector?›

Benchling operates in Biotech/Research Software, and Solugen operates in Biotech / Green Chemistry.

How do Benchling and Solugen compare in valuation?›

Benchling is valued at $6.1B, and Solugen at $2B.

How old are Benchling and Solugen?›

Benchling launched in 2013; Solugen launched in 2016.

What's the team size at Benchling versus Solugen?›

Benchling employs around 605 people; Solugen employs around 115.

Is Benchling from the same country as Solugen?›

Benchling is headquartered in United States, and Solugen in United States.

Same pillar · company pairs

Neighbouring pairs in this sector

BioLinq vs Calyxocompany pair · health›
$684.6Mtop valuation1.7×gap
Benchling vs Signoscompany pair · health›
$6.1Btop valuation6.1×gap
BioLinq vs Egenesiscompany pair · health›
$400Mtop valuation1.1×gap
Benchling vs Pristyn Carecompany pair · health›
$6.1Btop valuation4.4×gap
Calyxo vs Kriya Therapeuticscompany pair · health›
$684.6Mtop valuation3.4×gap
Benchling vs Neuralinkcompany pair · health›
$9Btop valuation1.5×gap
Alloy Therapeutics vs HistoSonicscompany pair · health›
$2.2Btop valuation2.2×gap
Abridge vs Alloy Therapeuticscompany pair · health›
$5.3Btop valuation5.3×gap
Keep exploring
More pairs in Health
Calyxo vs Egenesiscompare · versus›Benchling vs Kry (Livi)compare · versus›Alloy Therapeutics vs Zocdoccompare · versus›HistoSonics vs Neuralinkcompare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Health

Trade 86 markets on Canborsa

Canborsa

Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.

Markets
Crypto perpetualsStock perpetualsGold & commoditiesIndex perpetualsAll markets ›
Companies
SpaceXOpenAIAnthropicStripeAll companies ›
Compare
Perp feesFunding ratesNo-KYC platformsCanborsa vs AvantisCanborsa vs OstiumAll comparisons ›
Learn
What is a perpetual?Funding rates explainedAirdrops & pointsAll guides ›
© Canborsa 2026TermsPrivacy